Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study
(NYSE: RCUS) Delayed: 29.66 -0.47 (1.56%)
Previous Close $30.13    52 Week High $ 
Open $29.64    52 Week Low $ 
Day High $30.10    P/E N/A 
Day Low $29.40    EPS $ 
Volume 736,983